Pharmaceuticals, Biotechnology and Life Sciences
DUBLIN–(BUSINESS WIRE)–The “Global Erectile Dysfunction (ED) Drugs Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering. The erectile dysfunction (ED)…
Apricus Biosciences, a biopharmaceutical company urology and rheumatology focused drug-maker, will have to fire another shot at getting its topical cream…
Futura Medical has filed a new formulation patent for its topical gel for the treatment of erectile dysfunction, with the UK Intellectual Property Office in connection with MED2002.
Futura Medical’s pivotal efficacy study of MED2002, a novel gel for the treatment of erectile dysfunction (ED) is underway and recruitment of patients for the study is proceeding well, with 118 patients having enrolled in the study to date.